Edition:
United States

Indivior PLC (INDV.L)

INDV.L on London Stock Exchange

46.86GBp
22 May 2019
Change (% chg)

0.04 (+0.09%)
Prev Close
46.82
Open
47.50
Day's High
49.24
Day's Low
46.55
Volume
4,727,907
Avg. Vol
5,861,860
52-wk High
504.60
52-wk Low
20.98

About

Indivior PLC (Indivior) is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence (the Indivior Business). Its treatment and pipeline focus is opioid use disorder, alcohol use disorder, overdose rescue... (more)

Overall

Beta: --
Market Cap(Mil.): £2,498.61
Shares Outstanding(Mil.): 721.46
Dividend: --
Yield (%): --

Financials

  INDV.L Industry Sector
P/E (TTM): 48.23 29.30 32.55
EPS (TTM): 0.07 -- --
ROI: 25.75 14.23 13.82
ROE: -- 15.46 15.24

Indivior signs deal to sell schizophrenia drug in Canada

British drugmaker Indivior Plc on Thursday signed a licensing agreement with HLS Therapeutics Inc for the sale of its schizophrenia drug Perseris in Canada.

May 09 2019

Indivior signs deal to sell schizophrenia drug in Canada

May 9 British drugmaker Indivior Plc on Thursday signed a licensing agreement with HLS Therapeutics Inc for the sale of its schizophrenia drug Perseris in Canada.

May 09 2019

Indivior's Suboxone decline slower than feared as company bets on new opioid drug

Indivior Plc's best selling drug is losing market share slower than some analysts had predicted and its new drug is performing on target, lifting shares in the company despite its forecast of a possible loss this year.

May 02 2019

UPDATE 3-Indivior's Suboxone decline slower than feared as company bets on new opioid drug

* Stock closes up 5.2 percent (Adds graphics, CFO comment, details on DoJ investigation)

May 02 2019

Indivior shares plummet, Reckitt hurt on U.S. charges over opioid prescriptions

(This April 10 story refiles to fix scrambled syntax in paragraph five)

Apr 11 2019

REFILE-UPDATE 6-Indivior shares plummet, Reckitt hurt on U.S. charges over opioid prescriptions

* Indivior charged in the United States with conspiracy, fraud

Apr 11 2019

European stocks tick up post ECB decision, banks fall

European shares rose slightly on Wednesday as gains across most sectors offset losses among lenders, which were hit by a lack of detail in European Central Bank (ECB) comments after the bank left borrowing costs unchanged.

Apr 10 2019

UPDATE 2-European stocks tick up post ECB decision, banks fall

* Novartis among top healthcare losers after Morgan Stanley downgrades (Updates to close)

Apr 10 2019

Indivior shares tank after U.S. indictment for illegal marketing

April 10 Shares of Indivior Plc sank 44 percent on Wednesday after the U.S. Justice Department accused the British drugmaker of illegally boosting prescriptions for the film version of its blockbuster opioid addiction treatment Suboxone.

Apr 10 2019

U.S. indicts Indivior over Suboxone opioid treatment marketing

The U.S. Justice Department announced on Tuesday the indictment of Indivior Plc and a subsidiary on charges they engaged in an illegal scheme to boost prescriptions of the film version of its opioid addiction treatment Suboxone.

Apr 09 2019

Earnings vs. Estimates